Neuropsychiatric Disease and Treatment

Title Publication Date Language Citations
Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder2006/01/01English7
Memantine combined with an acetyl cholinesterase inhibitor ? hope for the future?2006/01/01English7
The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder2006/01/01English7
The four As associated with pathological Parkinson disease gamblers: anxiety, anger, age, and agonists2007/02/01English7
Venlafaxine in the treatment of panic disorder2007/02/01English7
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?2005/01/01English7
Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study2006/09/01English7
The use of combination therapies in the acute management of migraine2006/09/01English7
Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia2006/12/01English6
New agents in the treatment of premature ejaculation2006/12/01English6
Acamprosate: a new tool in the battle against alcohol dependence2006/12/01English6
Cognitive impairment in elderly women: the relative importance of selected genes, lifestyle factors, and comorbidities2006/01/01English6
Hormones and dementia ? a comparative study of hormonal impairment in post-menopausal women, with and without dementia2006/01/01English6
Genetic and molecular aspects of spinocerebellar ataxias2005/01/01English6
Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barr� syndrome: some preliminary observations2005/01/01English6
Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders2005/01/01English5
Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder2006/12/01English5
Clinical variables and implications of the personality on the outcome of bipolar illness: a pilot study2007/04/01English5
Pathological gambling and dopamine agonists: A phenotype?2007/02/01English4
Impaired cognition and attention in adults: pharmacological management strategies2007/02/01English4
Changes in peripheral benzodiazepine receptors in patients with bipolar disorder2005/01/01English4
Dietary essential fatty acids and gender-specific behavioral responses in cranially irradiated rats2006/09/01English4
Longitudinal neurocognitive outcome in an adolescent with Hurler-Scheie syndrome2006/09/01English4
Uneven focal shoe deterioration in Tourette syndrome2006/12/01English4
CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer's disease2006/01/01English3
A survey of fi ve antidepressant properties infl uencing clinician's treatment choices in MDD2007/02/01English3
Migraine ? a suitable case for treatment?2006/09/01English2
Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients2007/02/01English2
Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan2007/02/01English2
The schizophrenias, the neuroses and the covered wagon; a critical review2007/02/01English2